{"output": [["Tetraphase Pharmaceuticals", "COMP", "Promote", "Larry Tsai", "PERSON"], ["Larry Tsai", "PERSON", "Become", "Chief Medical Officer", "ORG/REG"], ["Larry Tsai", "PERSON", "Provide", "Significant Expertise", "CONCEPT"], ["Larry Tsai", "PERSON", "Lead", "Clinical Team", "CONCEPT"], ["Tetraphase Pharmaceuticals", "COMP", "Operate_In", "Clinical Stage Biopharmaceutical Company", "ORG"], ["Tetraphase Pharmaceuticals", "COMP", "Develop", "Novel Antibiotics", "PRODUCT"], ["Novel Antibiotics", "PRODUCT", "Treat", "Life-threatening Multidrug-resistant Infections", "CONCEPT"], ["Tetraphase Pharmaceuticals", "COMP", "Have", "Pipeline Programs", "CONCEPT"], ["Tetraphase Pharmaceuticals", "COMP", "Move Forward", "New Drug Application Regulatory Process", "CONCEPT"], ["Tetraphase Pharmaceuticals", "COMP", "Await", "Topline Data Readout", "CONCEPT"], ["Larry Tsai", "PERSON", "Hold", "Bachelor of Science in Biology", "EDUCATION"], ["Larry Tsai", "PERSON", "Hold", "M.D.", "EDUCATION"], ["Larry Tsai", "PERSON", "Board Certified", "Critical Care Medicine", "CONCEPT"], ["Larry Tsai", "PERSON", "Board Certified", "Internal Medicine", "CONCEPT"], ["Larry Tsai", "PERSON", "Board Certified", "Pulmonary Disease", "CONCEPT"], ["Tetraphase Pharmaceuticals", "COMP", "Create", "Novel Tetracycline Analogs", "CONCEPT"], ["Tetraphase Pharmaceuticals", "COMP", "Have", "Proprietary Technology Platform", "CONCEPT"], ["Tetraphase Pharmaceuticals", "COMP", "Include", "Three Antibiotic Clinical Candidates", "CONCEPT"], ["Tetraphase Pharmaceuticals", "COMP", "Have", "Investor Contacts", "CONCEPT"], ["Tetraphase Pharmaceuticals", "COMP", "Have", "Media Contact", "CONCEPT"]], "published": "2018-01-03T00:35:00.000+02:00"}